Cartesian Therapeutics, Inc.
RNAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001453687
No open-market purchases or sales by Cartesian Therapeutics, Inc. insiders were filed in the last 90 days; 94 institutions reported holding it in 13F filings for Q2 2026, worth $90.4M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Cartesian Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 93 | 97 | +4 |
| Shares | 60.6M | 63.7M | +3.11M (+5.1%) |
| Value | $79.3M | $104.9M | +$25.6M (+32.2%) |
New holders (20)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of Montreal | 1,054,700 | $2.30M | 0.00% |
| Healthcare of Ontario Pension Plan Trust Fund | 720,800 | $1.18M | 0.01% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 528,044 | $866.0K | 0.00% |
| Ally Bridge Group (NY) LLC | 334,255 | $548.0K | 0.36% |
| First Trust Advisors LP | 301,253 | $494.0K | 0.00% |
| Dimensional Fund Advisors LP | 139,637 | $229.0K | 0.00% |
| Cornercap Investment Counsel Inc | 100,854 | $165.0K | 0.03% |
| Caxton Associates LP | 97,193 | $159.0K | 0.03% |
| Lazard Asset Management LLC | 48,365 | $79.0K | 0.00% |
| Belvedere Trading LLC | 44,270 | $75.0K | 0.08% |
| Bayesian Capital Management, LP | 44,274 | $73.0K | 0.01% |
| Virtu Financial LLC | 22,925 | $38.0K | 0.00% |
| Occudo Quantitative Strategies LP | 20,453 | $34.0K | 0.00% |
| Bridgeway Capital Management, LLC | 19,200 | $31.0K | 0.00% |
| Beacon Pointe Advisors, LLC | 19,000 | $31.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 15,300 | $25.0K | 0.00% |
| UBS Group AG | 11,102 | $18.0K | 0.00% |
| Point72 Hong Kong Ltd | 2,219 | $4.00K | 0.00% |
| China Universal Asset Management Co., Ltd. | 1,430 | $2.00K | 0.00% |
| CWM, LLC | 6 | $0 | 0.00% |
Sold out (16)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| AQR Capital Management LLC | 1,287,949 | $1.69M |
| K2 Principal Fund, L.P. | 1,013,927 | $1.33M |
| Ergoteles LLC | 366,000 | $479.0K |
| HRT Financial LP | 141,626 | $185.0K |
| Two Sigma Securities, LLC | 37,651 | $49.0K |
| Private Advisor Group, LLC | 35,200 | $46.0K |
| Squarepoint Ops LLC | 27,760 | $36.0K |
| Boothbay Fund Management, LLC | 26,785 | $35.0K |
| Balyasny Asset Management LLC | 23,642 | $31.0K |
| Y-Intercept (Hong Kong) Ltd | 13,534 | $18.0K |
| SG Americas Securities, LLC | 11,563 | $15.0K |
| Pinz Capital Management, LP | 10,600 | $14.0K |
| Captrust Financial Advisors | 1,500 | $2.00K |
| New York State Common Retirement Fund | 890 | $1.00K |
| The PNC Financial Services Group, Inc. | 56 | $0 |
| Moisand Fitzgerald Tamayo, LLC | 100 | $0 |